Azimuth Biologics

The Challenge

Flaviviruses are one of the most significant global infectious disease threats.

Spread by the bite of infected mosquitos, hundreds of millions of people are infected by flaviviruses every year, resulting in tens of thousands of deaths and billions of dollars of lost economic output

 

While the flavivirus family is large and diverse, dengue virus (DENV) and Zika virus (ZIKV) are the two members that remain widespread, significant, and persistent public health challenges. Both DENV and ZIKV are most commonly found in the tropics and sub-tropics. However, factors such as climate change and increased global travel means that outbreaks of these viruses are now observed in Europe and the United States.

 

Dengue Virus

  • Dengue is a disease caused by infection with one of the four serotypes of dengue virus 
  • DENV infects nearly 400 million individuals every year, with nearly 3 billion people at risk of infection
  • DENV infection most often results in flu-like symptoms, but can progress to life-threatening Dengue Hemorrhagic Fever in a fraction of infected individuals
  • A single DENV infection does NOT provide you protection from infection from all 4 DENV serotypes
  • Rather, the IgG antibodies generated by your first infection can increase the number of infected cells during your second infection with a different DENV serotype, resulting in more severe disease

Links for more information on Dengue:

Zika Virus

  • Zika virus (ZIKV) is closely related to DENV and can be transmitted by the same family of mosquitos

  • Most ZIKV infections are mild or asymptomatic in healthy/immunocompetent patients but is associated with Guillain-Barré syndrome, neuropathy and myelitis in a fraction of infected individuals

  • However, ZIKV infection during pregnancy can result in significant harm to the developing fetus, including microcephaly and other congenital malformations as well as preterm birth and miscarriage

  • Microcephaly and other congenital malformations are associated with virus transmission from the mother’s bloodstream, across the placenta, to the developing fetus.

  • While the factors that influence maternal/fetal transmission of ZIKV are incompletely understood, increasing evidence – including recent non-human primate studies – suggest that ZIKV-reactive IgG antibodies generated by prior flavivirus infections can facilitate fetal ZIKV infection by shepherding the virus across the placenta as part of antibody/virus immune complexes (Reference One, Reference Two)  

Links for more information on Zika: